FTC Consumer Protection Weekly (28 Sep to 5 Oct 2026): Pricing Transparency Dominates

Executive Summary

The FTC's consumer protection week centred on one theme: whether the price a consumer sees is the price they pay. The agency sued Lens.com over a hidden "Taxes & fees" charge, sent pricing warning letters to 24 large healthcare services companies, and settled a franchise-disclosure case for $1.85 million. Coverage here is limited to items I could confirm on FTC.gov, the House member site and press reports; I did not check the Federal Register or Congress.gov directly, so rule dockets and bill numbers beyond those cited are not covered.

Two policy signals matter beyond the cases. On 30 September, the FTC confirmed to CNBC that it has opened an investigation into OpenAI, Anthropic and other AI companies over product risks; it declined to name other targets (CNBC). And on 1 October Reps. Schakowsky and Castor announced bills to widen FTC rulemaking and civil-penalty powers (Rep. Schakowsky). The bills are unlikely to move quickly (my judgement; no vote or scheduling was found), so compliance teams should plan around enforcement under existing law: FTC Act Section 5, ROSCA and the Franchise Rule.

Enforcement: Hidden Fees, Franchise Earnings Claims and Healthcare Pricing

Lens.com (2 October). The FTC, with the Utah and Nevada attorneys general, sued Lens.com Inc., its owner Cary Samourkachian and Speed Commerce LLC. The complaint alleges advertised prices were artificially low, with a mandatory "Taxes & fees" charge that routinely doubles the price and was placed below the visible part of the checkout screen. It further alleges the label wrongly implies sales tax, and that the "AutoRefill" subscription failed to clearly disclose the fee or how and when to cancel. Claims cite the FTC Act, ROSCA, the Gramm-Leach-Bliley Act and Utah and Nevada state laws. The vote to file was 2-0, in the District of Nevada; the case is allegations only and will be decided by the court.

Premier Martial Arts franchisor (5 October). Premier Franchising Group (PFG) and its former sales organization Franchise Fastlane (FFL) will pay $1.85 million under proposed settlements. The FTC alleges they claimed non-martial-artists could profitably run studios semi-absentee in under 15 hours a week, drawing in more than 200 buyers who paid initial fees of $49,500 or more. It also alleges PFG's 2020 to 2022 disclosure documents reported earnings from existing studios that were materially different from what new franchisees would operate. The PFG order carries a $3,875,424 judgment, partly suspended on payment of $650,000, while FFL pays $1.2 million. PFG must also offer certain franchisees penalty-free cancellation. The vote was 2-0, filed in the Eastern District of Tennessee.

Healthcare price transparency warning letters (5 October). Chairman Ferguson sent letters to 24 of the largest healthcare services companies. The letters state that CMS price transparency compliance is not a safe harbor under Section 5, and that incomplete disclosures, such as omitting physician or facility fees, may be deceptive. They also state that missing or late pricing for scheduled care may be unfair. The release links the effort to a Healthcare Task Force created earlier in 2026 and to the Lens.com suit.

Competition-side items (outside this brief's scope). FTC.gov also lists a settlement with Southern Glazer's Wine and Spirits LLC on alleged price discrimination (2 October) and a Corteva antitrust settlement (28 September) (FTC press release index). I did not review their terms.

Date	Matter	Headline money / action	Source
2 Oct	Lens.com (litigated complaint)	Hidden "Taxes & fees"; ROSCA and FTC Act claims; no penalty yet	FTC
5 Oct	PFG / FFL (proposed settlements)	$1.85M to compensate franchisees; cancellation option	FTC
5 Oct	24 healthcare companies (warning letters)	No penalty; notice of Section 5 expectations	FTC

Policy and Rulemaking: Impersonation Scam Rule and AI Probe

I saw no new final consumer protection rule in the FTC press release listings I reviewed for the week. The most relevant open item is just before the window: on 24 September the FTC announced an Advance Notice of Proposed Rulemaking on its Rule on Impersonation of Government and Businesses. It asks whether to require platforms to curb ad-optimization tools that help scammers, by amending the rule, writing a new one, or acting non-regulatorily. Comments are due 60 days after Federal Register publication. I did not confirm the publication date, so the deadline is unconfirmed. The FTC cited roughly $3.5 billion in reported impersonation losses in 2025. Other recent items on the FTC list include a 9 September withdrawal of the 2021 health-apps breach policy statement and a September extension of the personalized pricing policy statement comment period (FTC press release index).

The AI probe is the week's biggest unknowns. CNBC reported it as an investigation into product risks, first reported by the New York Post, with no further targets named and no public FTC release found by me (CNBC). The report came one day after AI executives signed a voluntary, nonbinding safety accord at the White House, per the same CNBC article.

Congress: Bills to Expand FTC Powers

On 1 October Reps. Schakowsky and Castor announced two bills. The FTC Autonomy Act would let FTC attorneys seek civil penalties without first enlisting the Department of Justice. The 21st Century FTC Act would give the FTC streamlined Administrative Procedure Act rulemaking and allow civil penalties for first-time FTC Act violations (same source). I found no committee scheduling for either bill.

Compliance Implications and Watch List

Show the total price up front. The Lens.com complaint alleges a mandatory fee sat below the visible part of the checkout screen, and the hospital letters target incomplete price disclosure. The FTC links the two actions, so I read both as warnings to show mandatory charges clearly (my inference).
Audit subscription flows. The Lens.com complaint pairs hidden fees with unclear cancellation terms under ROSCA.
Franchisors: substantiate earnings claims. Existing-unit results must be representative of new units, or the differences must be disclosed.
Healthcare providers: CMS compliance is not enough. Check physician and facility fees and advance-notice timing.
Platforms and ad-tech: watch the impersonation ANPRM and prepare comments once the deadline is confirmed.
Frontier AI developers: expect information requests; scope is not public.